Atsushi Arakawa
Overview
Explore the profile of Atsushi Arakawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onagi H, Horimoto Y, Okano S, Sasa K, Ishizuka Y, Ichida M, et al.
Histopathology
. 2024 Dec;
86(5):750-761.
PMID: 39628362
Aims: In non-small cell lung cancer, alterations in mesenchymal-epithelial transition (MET) have been recognized as novel therapeutic targets. In particular, the MET exon 14 skipping mutation (METex14s) is a rare...
2.
Asakura T, Hashimoto T, Ando T, Tomita N, Matsumoto T, Arakawa A, et al.
Juntendo Iji Zasshi
. 2024 Jul;
68(4):363-368.
PMID: 39021430
Objectives: The goal of the study was to examine the relationships among micrometastasis, pathological degree of differentiation and survival in patients with esophageal squamous cell carcinoma (SCC). Design: A single-center...
3.
Koyanagi A, Kajino K, Nojiri S, Abe M, Kobayashi T, Sugitani Y, et al.
Juntendo Iji Zasshi
. 2024 Jun;
69(2):124-136.
PMID: 38854453
Objectives: ERC/mesothelin is a glycosylphosphatidylinositol (GPI)-anchor protein expressed in mesothelioma. A precursor protein is cleaved by proteases and an N-terminal fragment (N-ERC) is extracellularly secreted. A remaining C-terminal fragment (C-ERC)...
4.
Yaguchi A, Fujimura J, Ikuse T, Suzuki M, Shimizu Y, Hisata K, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(7):e31003.
PMID: 38605542
No abstract available.
5.
Abe E, Suzuki M, Ichimura K, Arakawa A, Satomi K, Ogino I, et al.
World Neurosurg
. 2024 Mar;
185:e1019-e1029.
PMID: 38479644
Background: Ependymoma is a central nervous system (CNS) tumor that arises from the ependymal cells of the brain's ventricles and spinal cord. The histopathology of ependymomas is indistinguishable regardless of...
6.
Saeki H, Horimoto Y, Hlaing M, Men Y, Rong L, Ishizuka Y, et al.
Oncol Lett
. 2023 Nov;
27(1):9.
PMID: 38034487
Tamoxifen (TAM), a selective estrogen receptor modulator, is often used for long-term adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer. TAM is known to increase the risk of...
7.
Nikai K, Koga H, Suda K, Miyahara K, Lane G, Arakawa A, et al.
Pediatr Surg Int
. 2023 Nov;
40(1):15.
PMID: 38032513
Purpose: To evaluate common hepatic duct just distal to the HE anastomosis (d-CHD) prospectively for mucosal damage, inflammation, fibrosis, dysplasia, carcinoma in situ, malignant transformation, effects of serum amylase, and...
8.
Nakajima H, Suda K, Arakawa A, Yanai T
Clin Case Rep
. 2023 May;
11(5):e7310.
PMID: 37215961
Key Clinical Message: Several animal experiment studies have shown that insufficient testicular descent to the scrotum can be caused by persistence of cranial suspensory ligament (CSL). We report a case...
9.
Yuan M, Saeki H, Horimoto Y, Ishizuka Y, Onagi H, Saito M, et al.
Int J Surg Pathol
. 2023 May;
32(2):223-229.
PMID: 37157807
Fibroadenoma (FA) and benign phyllodes tumor (PT) of the breast often have similar appearances on imaging. While an exact diagnosis of biopsy specimens is required to choose adequate treatment, including...
10.
Semba R, Horimoto Y, Sakata-Matsuzawa M, Ishizuka Y, Denda-Nagai K, Fujihira H, et al.
Sci Rep
. 2023 Mar;
13(1):5281.
PMID: 37002293
Adjuvant chemotherapy has played a major role in the treatment of hormone receptor-positive breast cancer for many years. To better determine which patient subsets need adjuvant chemotherapy, various gene expression...